A comprehensive narrative review evaluating the neurobiology of thermosensation demonstrates that innocuous cool perception and noxious cold pain rely on distinct yet partially overlapping molecular and neural architectures organized across five sequential stages. Published by researchers Alexander F. G. Hagström and Rania Nuwailati, the synthesis evaluates evidence spanning transduction, peripheral transmission, spinal modulation, central projection, and cortical activation with descending brainstem control. Although thermal sensations play dual roles in physiological thermoregulation and protective nociception, the mechanisms governing normal and abnormal cold perception have historically remained underexplored relative to other somatosensory modalities. By compiling experimental and clinical evidence from database inception through January 2025, the authors screened 1,140 initial records to assess 198 full-text articles across PubMed, Semantic Scholar, and Google Scholar. The resulting framework provides a stepwise structure illustrating how peripheral inputs are transduced, transmitted along primary afferents, integrated in the spinal cord, and interpreted across supraspinal networks, while proposing underrecognized molecular targets that may drive chronic neuropathic hypersensitivity.
Clinical and experimental cold sensitivity exhibits substantial variation across demographic groups, with age and biological sex identified as the most consistent modulators of thermal thresholds. Systematic evidence confirms that females frequently demonstrate greater sensitivity to cold, displaying significantly lower cold pain thresholds, which mark the temperature where pain is first detected, alongside lower cold pain tolerances, where maximum pain is reached. In a systematic review examining thirty-two investigations, eighty percent reported significantly lower cold pain tolerances in females, a directional pattern corroborated by large cohorts of several hundred participants. These differences reflect combined physiological and psychological influences, including pain-related fear and anxiety linked to amygdala activation, as well as membrane-initiated hormonal signaling. In preclinical models, administration of beta-estradiol produced a non-significant trend toward reduced TRPM8 expression in ovariectomized rodents, suggesting potential hormonal modulation that remains hypothesis-generating in humans. Conversely, aging is characterized by sensory decline, with older adults exhibiting elevated detection and pain thresholds driven by peripheral nerve fiber reduction and blunted central integration, which paradoxically increases vulnerability to cold injury while obscuring sensory loss during diagnostic evaluations.
Genetic polymorphisms and psychosocial traits further diversify individual cold responses across healthy and clinical populations. Human genetic studies reveal that functional single nucleotide polymorphisms in the TRPM8 channel, such as the rs12992084 variant, correlate with decreased noxious cold sensitivity, whereas variants in the fatty acid amide hydrolase gene alter endocannabinoid signaling to reduce pain sensitivity and analgesic consumption. Alterations in purinergic P2RX7 receptors and monoaminergic regulators, including dopamine active transporter-1 and monoamine oxidase-A, have similarly been associated with shifted cold pain tolerance, though many identified associations exhibit modest effect sizes awaiting independent replication. Alongside genetic contributors, psychological dispositions strongly shape sensory interpretation and affective tolerance. Individuals scoring high in avoidance-related traits such as neuroticism display pronounced negative affective reactions, including discomfort and shivering during cold exposure, whereas those high in extraversion frequently report neutral or positive sensory experiences like tingling. These findings emphasize that individualized pain assessment requires interpretation against age-, sex-, and context-stratified normative datasets rather than broad, unadjusted standards.
At the initial stage of cold transduction, specialized primary afferent nerve endings translate environmental temperature drops into electrochemical signals through distinct ion channel families. Transient Receptor Potential Melastatin 8, known as TRPM8, is established as the sole unequivocal cold transducer in mammals, activating at moderate cooling temperatures beginning around 28 degrees Celsius to induce non-selective calcium and cation influx. Enriched in trigeminal and dorsal root ganglion neurons, TRPM8 is distributed across unmyelinated C-fibers, which constitute approximately seventy-six percent of expressing axons for sustained signaling, and small myelinated A-delta fibers, which comprise twenty-four percent for rapid, phasic signaling. TRPM8 afferents signal temperatures down to 10 degrees Celsius and comprise three functional subtypes: fibers responding selectively to innocuous cooling, those activated exclusively by noxious cold, and bimodal fibers responsive to both regimes. Although TRPM8 is essential for normal cool perception, knockout rodents retain noxious cold detection, indicating that complementary, TRPM8-independent molecular mechanisms operate during exposure to extreme, potentially damaging temperatures.
Alternative and auxiliary channels contribute critically to the transduction spectrum, particularly under inflammatory or tissue-damaging conditions. Transient Receptor Potential Canonical 5, or TRPC5, functions as a calcium-permeable channel activated between 25 and 37 degrees Celsius by phospholipase C-coupled cascades rather than chemical agonists like menthol. Although TRPC5 knockout mice lose approximately seventy percent of cold-sensitive dorsal root ganglion neurons in vitro, in vivo cold behaviors remain preserved due to compensatory functional shifts toward TRPM8. Nevertheless, TRPC5 is expressed in half of dental nociceptors and is indispensable for noxious cold sensing in odontoblasts, where blocking TRPC5 reduces tooth cold signaling by nearly sixty percent. Meanwhile, Transient Receptor Potential Ankyrin 1, or TRPA1, acts predominantly as a pro-modulatory sensor activated by oxidative stress and inflammatory mediators, driving cold hypersensitivity across diabetic neuropathy, chemotherapy-induced neuropathy, and complex regional pain syndrome. Additionally, the ionotropic kainate receptor subunit GluK2 mediates noxious cold transduction below 18 degrees Celsius via noncanonical metabotropic Gi/o G-protein signaling, with GluK2 knockout animals exhibiting deficits confined strictly to the noxious cold domain.
Following transduction, cold signals propagate along primary afferent neurons toward the central nervous system, a process coordinated by voltage-gated sodium, voltage-gated potassium, and two-pore domain potassium channels. Voltage-gated sodium channel Nav1.3, which exhibits sparse expression in the healthy adult rodent nervous system, is highlighted as a unique contributor to neuropathic cold hypersensitivity. Following peripheral nerve damage, Nav1.3 represents the only channel in its class that is consistently upregulated in injured and adjacent first- and second-order sensory neurons. Nav1.3 possesses distinct biophysical resistance to cooling and generates persistent sodium currents that promote pathological hyperexcitability. Experimental knockdown of Nav1.3 or administration of microRNAs targeting its transcript successfully reverses cold allodynia in rodent chronic constriction injury and diabetic models. While adult low baseline expression limits Nav1.3 participation in physiological cold sensing, its post-injury resurgence marks it as an appealing therapeutic candidate, though clinical compounds selectively targeting Nav1.3 without off-target effects have not yet demonstrated therapeutic efficacy.
Concurrently, the ADP-sensitive purinergic receptor P2Y1 plays an underrecognized but fundamental role in both physiological cold sensation and pathological hypersensitivity. Rodent knockout studies reveal that P2Y1-mediated excitation is required for normal noxious cold behaviors, as genetic deletion diminishes cold-evoked responses in polymodal C-nociceptors with minimal molecular overlap with TRPM8 or TRPA1 channels. Upon activation by adenosine diphosphate, P2Y1 mobilizes G-protein cascades that cleave phosphatidylinositol 4,5-bisphosphate into inositol 1,4,5-trisphosphate via phospholipase C, triggering calcium release from the endoplasmic reticulum while suppressing Kv7 potassium channel M-currents. Because Kv7 inhibition intrinsically enhances cold excitability, elevated ADP-to-ATP ratios resulting from mitochondrial dysfunction directly provoke cold hypersensitivity through sustained P2Y1 activation. Preclinical models of mitochondrial impairment and opioid-induced hypersensitivity show that pharmacological P2Y1 antagonism effectively normalizes pathological cold pain responses, identifying purinergic gating as a mechanistic node warranting expanded clinical exploration.
Central processing begins as primary afferent terminals deliver cold signals to second-order neurons within the spinal dorsal horn or spinal trigeminal nucleus through glutamate release. Primary afferents terminate in cytoarchitecturally defined laminae based on sensory modality: innocuous cool-responsive TRPM8 fibers project primarily to superficial laminae I and outer lamina II, whereas noxious cold fibers expressing TRPA1 terminate across laminae I, outer lamina II, inner lamina II, and deeper laminae V through VI. Synaptic transmission is tightly gated by local inhibitory interneurons, predominantly GABAergic in laminae I and outer lamina II, with additional glycinergic co-release in inner lamina II. In pathological states, loss of this inhibitory restraint—termed disinhibition—unmasks latent excitatory pathways and enables non-painful cool signals to trigger intense pain, manifesting as cold allodynia. Sustained glutamatergic signaling through kainate receptors containing GluK2 further fuels central sensitization and synaptic wind-up, while spinal microglia and astrocytes release inflammatory cytokines that exacerbate dorsal horn hyperexcitability.
Modulated cold signals ascend through two primary pathways that maintain functional segregation up to the brain: the spinothalamic tract and the spinoparabrachial tract. The spinothalamic pathway relays signals to thalamic targets, including the ventroposterolateral and ventroposteromedial nuclei, as well as the contested ventromedial posterior nucleus, before projecting to primary and secondary somatosensory cortices to encode spatial localization and stimulus intensity. In parallel, the spinoparabrachial tract directs ascending signals to the lateral parabrachial nucleus, which serves as a vital divergence point for homeostatic and behavioral responses. From the lateral parabrachial nucleus, efferent projections target the preoptic area of the hypothalamus to control autonomic thermoregulatory outputs such as shivering and cutaneous vasoconstriction, while concurrent projections to the central amygdala process the emotional salience and defensive avoidance behaviors provoked by noxious cold, preserving protective reflexes independently of thalamocortical sensory discrimination.
Supraspinal imaging reveals distinct cerebral activation signatures separating harmless cool perception from noxious cold exposure. Innocuous cooling consistently engages the bilateral posterior insular cortex and secondary somatosensory cortex, with primary somatosensory cortex activation largely absent. In contrast, noxious cold stimulates an expansive bilateral network with pronounced right-hemispheric lateralization, engaging the anterior insular cortex, anterior cingulate cortex, prefrontal cortex, and limbic structures. The anterior insula integrates sensory discrimination with interoceptive awareness, while the anterior cingulate cortex assigns emotional significance and distress to cold pain. In patients suffering from chronic cold hypersensitivity, functional neuroimaging demonstrates heightened resting-state connectivity between the insula and the amygdala, accompanied by altered top-down connectivity between frontal cortical regions and brainstem modulatory nuclei. Furthermore, electroencephalographic monitoring during cold exposure captures distinct shifts in beta, delta, and gamma spectral power, reflecting objective cortical signatures of nociceptive encoding and attentional processing.
Endogenous pain modulation is centrally orchestrated by the periaqueductal gray, which coordinates descending inhibition to filter nociceptive transmission at the spinal level. Two major efferent systems govern this control: the periaqueductal gray to rostral ventromedial medulla pathway, which employs serotonin, noradrenaline, enkephalins, and GABA to modulate dorsal horn neurons, and the locus coeruleus pathway, which delivers direct noradrenergic inhibition. Noradrenaline acts as the principal inhibitor of spinal cold nociception, whereas descending serotonergic influence is dual-directional, facilitating transmission via 5-HT3 receptors or suppressing it via 5-HT7 subtypes. Clinically, this descending circuitry is dynamically assessed using the cold pressor test within conditioned pain modulation protocols, where immersion in noxious cold serves as a conditioning stimulus that inhibits pain from a separate test stimulus. The cold pressor test exhibits high within- and between-session reliability and an exceptional safety profile, having been administered across more than 1,700 pediatric subjects without adverse events, while presenting lower burn risks than thermal contact heat.
Translating these mechanistic insights into personalized clinical medicine offers transformative opportunities for diagnostic phenotyping and targeted therapeutics. Cold-specific quantitative sensory testing, including cool detection thresholds and cold pain thresholds, reliably identifies early small-fiber dysfunction across peripheral neuropathies, often detecting pathology before heat-based measures show impairment. In pharmacotherapy trials, baseline cold thresholds have predicted clinical response; for example, patients responding to topical capsaicin patches exhibited significantly higher baseline cold pain thresholds, allowing patient stratification with high predictive accuracy. Emerging therapeutic strategies focus on selective antagonists against TRPM8 and TRPA1, modulators of Nav1.8 and Nav1.9 sodium channels, and purinergic P2Y1 inhibitors, alongside non-invasive brain stimulation targeting endogenous descending pathways. The authors emphasize that while narrative synthesis faces inherent publication bias toward positive findings and relies partly on preclinical models where human validation is emerging, establishing multimodal cold biomarkers will prove essential for achieving individualized, mechanism-based pain management.
Subject of Research: Neurobiological mechanisms of physiological and pathological cold sensation across molecular, spinal, and cortical pathways
Article Title: Molecular and neural mechanisms underlying physiological and pathological cold sensation
Article References: Hagström, A. F. G., & Nuwailati, R. (2026). Molecular and neural mechanisms underlying physiological and pathological cold sensation. Discover Neuroscience, 21(1), Article 93. https://doi.org/10.1186/s13064-026-00326-w
Image Credits: AI Generated
DOI: 10.1186/s13064-026-00326-w
Keywords: cold sensation, thermosensation, TRPM8, TRPA1, TRPC5, GluK2, Nav1.3, P2Y1, quantitative sensory testing, conditioned pain modulation, cold allodynia, cold hyperalgesia, dorsal horn, periaqueductal gray, neuropathic pain, cold pressor test, somatosensory processing
News Source: Ophelia Keating. (November 16, 2026). Review Details Stepwise Molecular Framework Underlying Physiological and Pathological Cold Sensation. Scienmag.



